Skip to main content
OpenTrials
Completed

NCT Number: NCT05712486

Manual Therapy for the Treatment of Athletic Pubalgia

Athletic osteitis pubis is a high prevalent pathology among athletes, especially in those who make quick change of direction of the movement, like runners or footballers. Despite the fact that there is evidence about conservative treatments, there is a lack of evidence about manual therapy (MT) techniques applied in isolation and its consequences in pain and range of movement. The investigators decided to conduct a randomized controlled trial to compare the effects of a MT technique with placebo technique.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Osteitis Pubis

Age range

18 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Silvia Lahuerta Martín

Soria, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Athletes diagnosed with osteitis pubis stage 1 with at least 3 months of evolution.
  • Internal rotation ROM limited.
  • Positive provocation pain tests.

Exclusion criteria

  • Pain due to intraarticular hip pathology.
  • Hip pain due to inflamatory diseases.
  • Previous surgical interventions in hip, pelvis or lumbar spine.
  • MRI results or provocation pain tests inconcluyent.

Treatment and study plan

High force hip Lateral distraction

Other

Hip lateral distraction in adjusted position of maximun flexion and internal rotation, with neutral position of abduction/adduction applying high force of distraction.

Placebo force hip lateral distraction

Other

Hip lateral distraction in adjusted position of maximun flexion and internal rotation, with neutral position of abduction/adduction applying placebo force of distraction.

Primary outcomes

  1. Actual PAIN

    Time frame: Baseline

    actual pain reported by the patient using visual analog scale (VAS) from 0 to 10, in which higher scores are worse.

  2. Actual PAIN

    Time frame: after to two weeks of treatment

    actual pain reported by the patient using visual analog scale (VAS)from 0 to 10, in which higher scores are worse.

  3. Last week PAIN

    Time frame: Baseline

    past week pain reported by the patient using visual analog scale (VAS) from 0 to 10, in which higher scores are worse.

  4. Last week PAIN

    Time frame: after to two weeks of treatment

    past week pain reported by the patient using visual analog scale (VAS) from 0 to 10, in which higher scores are worse.

Secondary outcomes

  1. Range of Movement (ROM)

    Time frame: Baseline

    Hip ROM as described by Pua et al. (2008)

  2. Range of Movement (ROM)

    Time frame: after to two weeks of treatment

    Hip ROM as described by Pua et al. (2008)

  3. Pain in sport activities

    Time frame: Baseline

    Appearance time of pain during activities

  4. Pain in sport activities

    Time frame: After two weeks of treatment

    Appearance time of pain during activities

  5. Pain intensity in pain provocation tests: Single adductor, squeeze and bilateral adductor tests

    Time frame: Baseline

    Appearance of pain during or after the execution of Single adductor, squeeze and bilateral adductor tests. If pain appears it will be reported by the patient using visual analog scale (VAS) from 0 to 10, in which higher scores are worse.

  6. Pain intensity in pain provocation tests: Single adductor, squeeze and bilateral adductor tests

    Time frame: After two weeks of treatment

    Appearance of pain during or after the execution of Single adductor, squeeze and bilateral adductor tests. If pain appears it will be reported by the patient using visual analog scale (VAS) from 0 to 10, in which higher scores are worse.

  7. Muscle function

    Time frame: Baseline

    Velocity (m/s), force (N) and power (W) evaluated for internal and external hip rotators with a rotary axis flywheel-encoder system.

  8. Muscle function

    Time frame: After two weeks of treatment

    Velocity (m/s), force (N) and power (W) evaluated for internal and external hip rotators with a rotary axis flywheel-encoder system.

  9. Functional capacity

    Time frame: Baseline

    Evaluated with a patient reported outcome questionnaire called Copenhagen Hip and Groin Outcome score (HAGOS) which assesses pain, symptoms, physical function in daily living, physical function in sport and recreation, participation in physical activities and hip and groin -related quality of life. For each item answer range from "never" to "always".

  10. Functional capacity

    Time frame: After two weeks of treatment

    Evaluated with a patient reported outcome questionnaire called Copenhagen Hip and Groin Outcome score (HAGOS) which assesses pain, symptoms, physical function in daily living, physical function in sport and recreation, participation in physical activities and hip and groin -related quality of life. For each item answer range from "never" to "always".

  11. Treatment credibility and expectancy

    Time frame: Day 1, before treatment

    Evaluated with Credibility and expectancy Questionaire (CEQ) in which the patient answer question related to the expectations of the intervention. Higher values mean better expectations on the therapy.

  12. Global Rating of Change

    Time frame: after to two weeks of treatment

    Subjective impression as described in GROC scale by Jaeschke, Singer & Guyat (1989)

  13. Group of treatment assignment

    Time frame: after to two weeks of treatment

    Question about which group of treatment was the patient assigned in.

Sponsors and collaborators

Lead sponsor

University of Valladolid

Other

Registry information

Official study title

Effects on Pain Anda Range of Motion of High Force Lateral Distraction Mobilization of the Hip in Athletes With Hip-related Groin Pain. A Randomized Controlled Trial.

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Feb 3, 2023
Registry last updated
Mar 25, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.